 Rare diseases specialist Amryt Pharma PLC NASDAQ:AMYT, LON:AMYT said the French authorities have signed off its drug Myalepta for reimbursement. The Ministry of Social Affairs and Health said it will pay for the use of the treatment as an adjunct to diet for those with leptin deficiency with congenital or acquired general lipodystrophy abnormal fat distribution in the body. 